Aguilera Jose, Hutt Erika, Jaber Wael A
Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH, United States.
Front Cardiovasc Med. 2021 Aug 24;8:729786. doi: 10.3389/fcvm.2021.729786. eCollection 2021.
Cardiac devices are frequently used in different cardiovascular conditions for the purpose of morbidity or mortality prevention. These include cardiac implantable electronic devices (CIED) like permanent pacemakers and implantable cardiac defibrillators, ventricular assistance devices (VADs), left atrial appendage occlusion (LAAO) devices like the Watchman™, atrial and ventricular septal occluders like the Amplatzer™, among others. In the past years, there has been an increase in the development of these devices as a result of a rise in the number of indications for implantation, paired with the aging and more medically complex patient population. This has led to an increase in the incidence of cardiac device-related infections, one of the most feared and serious complications which is associated with significant morbidity, mortality and financial burden. Accurate diagnosis of cardiac device-related infections is essential given the management implications which often involve removal of the infected device, removal of other prosthetic material and long-term antimicrobial therapy. Clinical and laboratory data are useful diagnostic tools but multimodality imaging is often necessary. The recently published 2020 European Heart Rhythm Association International Consensus document, which is endorsed by many expert societies, has recommended the use of multimodality imaging for the diagnosis of CIED infections. (1) This allows better disease characterization by identifying abnormal fluid collections and guiding aspiration for both diagnostic and therapeutic purposes (i.e. soft tissue ultrasound and computed tomography), evaluation for local extent of disease (i.e. transesophageal echocardiogram to evaluate for concomitant infective endocarditis), embolic manifestation of disease (i.e. computed tomography and magnetic resonance imaging) and metabolic tissue characterization (positron emission tomography and tagged white blood cell scan). (2) In addition, computed tomography (CT) allows for pre-procedural planning which has shown to be associated with better procedural outcomes.
心脏设备常用于不同的心血管疾病,以预防发病或死亡。这些设备包括心脏植入式电子设备(CIED),如永久起搏器和植入式心脏除颤器、心室辅助设备(VAD)、像Watchman™这样的左心耳封堵(LAAO)设备、像Amplatzer™这样的心房和心室间隔封堵器等。在过去几年中,由于植入适应症数量的增加,以及患者群体老龄化和医疗情况更复杂,这些设备的研发有所增加。这导致了心脏设备相关感染的发生率上升,这是最令人恐惧和严重的并发症之一,与显著的发病率、死亡率和经济负担相关。鉴于管理措施通常包括移除受感染的设备、移除其他假体材料和长期抗菌治疗,准确诊断心脏设备相关感染至关重要。临床和实验室数据是有用的诊断工具,但多模态成像通常是必要的。最近发表的2020年欧洲心律协会国际共识文件得到了许多专家协会的认可,推荐使用多模态成像来诊断CIED感染。(1)这可以通过识别异常积液并指导穿刺以用于诊断和治疗目的(即软组织超声和计算机断层扫描)、评估疾病的局部范围(即经食管超声心动图以评估是否合并感染性心内膜炎)、疾病的栓塞表现(即计算机断层扫描和磁共振成像)以及代谢组织特征(正电子发射断层扫描和标记白细胞扫描)来更好地表征疾病。(2)此外,计算机断层扫描(CT)可用于术前规划,这已被证明与更好的手术结果相关。